KIT DE ENZIMOINMUNOANÁLISIS PARA LA DETERMINACIÓN CUANTITATIVA DE USTEKINUMAB (ANTI- INTERLEUCINA 12 Y 23) Y DE ANTICUERPOS ANTI- USTEKINUMAB EN SUERO O PLASMA HUMANO - COFEPRIS Registration 1289R2024 SSA

Access comprehensive regulatory information for KIT DE ENZIMOINMUNOANÁLISIS PARA LA DETERMINACIÓN CUANTITATIVA DE USTEKINUMAB (ANTI- INTERLEUCINA 12 Y 23) Y DE ANTICUERPOS ANTI- USTEKINUMAB EN SUERO O PLASMA HUMANO (KIT DE ENZIMOINMUNOANÁLISIS PARA LA DETERMINACIÓN CUANTITATIVA DE USTEKINUMAB (ANTI- INTERLEUCINA 12 Y 23) Y DE ANTICUERPOS ANTI- USTEKINUMAB EN SUERO O PLASMA HUMANO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1289R2024 SSA and manufactured by INOCHEM, S.A. DE C.V.. The device was registered on May 06, 2024.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.